EFSA Issues Positive Safety Statement for the Use of Chromium Picolinate in EU Food Supplements

The European Food Safety Authority (EFSA) concludes no safety concerns for the use of chromium picolinate in food supplements, in response to Nutrition 21's Application to market Chromax(R) chromium picolinate in Europe . PURCHASE, N.Y., June 30 /PRNewswire-FirstCall/ -- Nutrition 21, Inc. ...

Syngenta Issues EUR 500 Million Eurobond

BASEL, Switzerland, June 23 /PRNewswire-FirstCall/ -- Syngenta announced today the successful issue of a EUR 500 million Eurobond with a five year maturity. The proceeds of the bond will be used for general funding purposes. John Ramsay, CFO, said: "We have taken advantage of favorable curren...

Industry Professionals Get Schooled in Real-World Oncology Issues at NCCN Academy

NCCN announces open registration for a west coast session of NCCN Academy for Excellence & Leadership in Oncology(TM) School of Pharmaceutical & Biotech Business scheduled for July 9 - 10, 2009 in San Francisco. This new educational offering is designed to give pharmaceutical and biotech p...

Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on GenSpera, Inc.

NEW YORK, June 2 /PRNewswire/ -- Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview(R) (EIO(R)) on GenSpera, Inc., a closely held company. The full 56-page report can be found at www.crystalra.com . GenSpera, Inc. ("GenSpera" or "the Com...

Antiviral Drugmaker Shares Soar as Swine Flu Spreads; Beacon Equity Issues Stock Alerts on: HEB, GNBT, BCRX, DVAX, NVAX, SVA

DALLAS, April 28 /PRNewswire/ -- BeaconEquity.com announces the availability of Stock Alerts on stocks making news today. As the influenza dominates the headlines, several biopharmaceutical stocks are parading up the charts. So how does swine flu affect the markets? Check out a video chart f...

Amylin Issues Statement in Response to Carl Icahn

SAN DIEGO, April 23 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) today issued the following statement from James N. Wilson, Lead Independent Director, on behalf of the Amylin Board of Directors: The Amylin Board of Directors welcomes continued three-way dialogue wi...

Crystal Research Associates, LLC Issues an Executive Informational Overview(R) (EIO(R)) on ACT Biotech, Inc.

NEW YORK, April 21 /PRNewswire/ -- Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview(R) (EIO(R)) on ACT Biotech, Inc. The full 56-page report can be found at www.crystalra.com . ACT Biotech, Inc. ("ACT Biotech" or "the Company") is a cl...

Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Neuralstem, Inc.

NEW YORK, April 6 /PRNewswire/ -- Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview(R) (EIO(R)) on Neuralstem, Inc. (NYSE Amex: CUR ). The full 56-page report can be found at www.crystalra.com . Neuralstem, Inc. ("Neuralstem" or "the ...

Beacon Equity Issues Trade Alerts on Market Movers: CAH, LEAP, FISV, PBG, ARNA, LEN

DALLAS, April 1 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today. Investors can view all of the daily trade alerts for free by visiting BeaconEquity.com/m . Today's Trade Alerts include: Cardinal Health Inc. (NYSE: CAH )...

NPSF Issues New Universal Patient Compact During Patient Safety Awareness Week

BOSTON, March 3 /PRNewswire/ -- In a concerted, nationwide effort to encourage and strengthen collaboration between patients, families, and their healthcare providers -- and create a powerful team for improved patient safety -- the National Patient Safety Foundation will introduce the Universa...

Beacon Equity Issues Technical Trade Alerts on Drug Manufacturer Stocks: FRX, TEVA, AGN, CEPH, VRTX, ADLR

DALLAS, Feb. 26 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today. Investors can view all of the daily trading notes for free by visiting: http://www.BeaconEquity.com/m Today's Trade Alerts include: Forest Laboratories I...

Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc.

NEW YORK, Feb. 13 /PRNewswire/ -- Crystal Research Associates, LLC announced today that it has issued an updated Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc. (BNC: TSX). The full 68-page report can be found at www.crystalra.com . Bioniche Life Sciences In...

FDA Issues Complete Response Letter for RISPERDAL(R) CONSTA(R) for the Adjunctive Maintenance Treatment of Bipolar Disorder

TITUSVILLE, N.J., Feb. 10 /PRNewswire-FirstCall/ -- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) announced today that the Food and Drug Administration (FDA) has asked for additional information regarding the company's supplemental New Drug Application (sNDA)...

Neurosurgery Journal Issues Supplement Dedicated to CyberKnife Radiosurgery Experience

SUNNYVALE, Calif., Jan. 30 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that Neurosurgery, the official journal of the Congress of Neurological Surgeons, has issued a peer-reviewed supplement dedicated to CyberK...

ETHEX Corporation Issues Nationwide Voluntary Recall of Products

ST. LOUIS, Jan. 28 /PRNewswire-FirstCall/ -- ETHEX Corporation, a subsidiary of KV Pharmaceutical (NYSE: KVa/KVb), is issuing, as previously disclosed by KV Pharmaceutical Company on January 26, 2009, a nationwide voluntary recall of the products identified below (all lots within their expirat...

Ther-Rx Corporation Issues Nationwide Voluntary Recall of Products

ST. LOUIS, Jan. 28 /PRNewswire-FirstCall/ -- Ther-Rx Corporation, a subsidiary of KV Pharmaceutical (NYSE: KVa/KVb), is issuing, as previously disclosed by KV Pharmaceutical Company on January 26, 2009, a voluntary nationwide recall of the products identified below (all lots within expiration)...

FDA Issues Complete Response Letter to SCOLR Pharma's Abbreviated New Drug Application for CDT(R) 12-Hour Pseudoephedrine

BOTHELL, Wash., Jan. 20 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (Amex: DDD ) today announced that the U. S. Food and Drug Administration (FDA) has issued a Complete Response letter for its Abbreviated New Drug Application (ANDA) for pseudoephedrine. The application, filed by SCOLR on Augus...

FDA Issues Complete Response Letter for Iclaprim

REINACH Switzerland, January 19 /PRNewswire-FirstCall/ -- Arpida Ltd. (SWX: ARPN) announces today that it has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for intravenous iclaprim for the treatment of complicated ...

Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance

CARY, N.C., Dec. 11 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (Nasdaq: CRTX ), a specialty pharmaceutical company focused on developing and commercializing prescription medications for respiratory disorders, today provided an update on the status of its integration activities follo...

Intellect Neurosciences, Inc. Issues Letter to Shareholders From Its Chairman and CEO

NEW YORK, Nov. 21 /PRNewswire-FirstCall/ -- Intellect Neurosciences, Inc. ( OTC Bulletin Board : ILNS ), a biopharmaceutical company focused on development of disease-modifying therapeutic agents for the treatment and prevention of Alzheimer's disease released today the following Letter to Shar...

Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on The Medical House PLC

NEW YORK, Nov. 10 /PRNewswire/ -- Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview(R) (EIO(R)) on The Medical House PLC (LSE: MLH.L), based in Sheffield, United Kingdom. The full 48-page report can be found at http://www.crystalra.com . ...

OTC Financial Network Issues Corporate Profile on ProtoKinetix Inc.

VANCOUVER, British Columbia, Oct. 28 /PRNewswire-FirstCall/ -- ProtoKinetix Inc. (OTC Bulletin Board: PKTX), a biotech company focused on the research, development and commercialization of patented anti-aging glycopeptides (AAGPs(TM)), announced today that OTC Financial Network (OTCFN), a divi...

FDA Issues Draft Guidance on Priority Review Vouchers

-BIO Ventures for Global Health to Work with Industry to Educate, Promote PRV Program- WASHINGTON, Oct. 20 /PRNewswire-USNewswire/ -- BIO Ventures for Global Health (BVGH) today announced its support of the US Food and Drug Administration's (FDA) release of Draft Guidance for Industry on Pri...

Resverlogix Issues a Management Statement

TSX Exchange Symbol: RVX CALGARY, Oct. 7 /PRNewswire-FirstCall/ - Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that in light of the recent significant market drop of Resverlogix shares management feels it is prudent to restate that the company fundamentals rem...

SectorWatch.biz Issues MarketStats on Agri-Biotech Equities YGYB, GRO, SEED, MON, ADM, and BG

IRVINE, Calif., Sept. 9 /PRNewswire/ -- SectorWatch.biz announces the availability of MarketStats for agri-biotech equities in the news and driving markets today. MarketStats offers a perspective on the aforementioned equities and the opportunity for investors to respond with articles, blogs a...

Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Generex Biotechnology Corporation

NEW YORK, Aug. 20 /PRNewswire/ -- Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview(R) (EIO(R)) on Generex Biotechnology Corporation (Nasdaq: GNBT ). The full 64-page report can be found at http://www.crystalra.com . Generex Biotechnolo...

BeaconEquity.com Issues Trade Alerts on Biotechnology Stocks: ELN, PFE, AMGN, DNA, BIIB, GILD

DALLAS, Aug. 18 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today. Investors can view all of the daily trading notes for free by visiting: http://www.BeaconEquity.com/m Today's Trade Alerts include: Elan Corp. plc (NYSE: ELN ), Pfize...

Arbitration Panel Issues Ruling in Distribution Dispute

WALTHAM, Mass., July 25 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (Amex: IMA ), a leading provider of rapid diagnostic products and health management services, announced that it received today a decision from an arbitration tribunal. That decision, directed at Inverness' B...

ActivBiotics Assignee Issues First Distribution of Cash to Creditors

WELLESLEY HILLS, Mass., June 19 /PRNewswire/ -- Joseph F. Finn, Jr., C.P.A. ("Finn") the Assignee for the Benefit of Creditors of ActivBiotics, Inc. ("ActivBiotics") announced today the first distribution of cash to the creditors of ActivBiotics. The distribution signifies the substantial comp...

Neuftec Issues Patent Infringement Proceedings in the UK Against Oxonica

ROSEAU, Commonwealth of Dominica, June 12 /PRNewswire/ -- Neuftec Limited, the proprietor of the original nano-particulate cerium Oxide fuel catalyst technology, today commenced patent infringement litigation in the UK against Oxonica Energy Limited, a wholly owned subsidiary of Oxonica PLC . ...

Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Arana Therapeutics Ltd.

NEW YORK, June 5 /PRNewswire/ -- Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview(R) (EIO(R)) on Arana Therapeutics Ltd. (AAH: ASX). The full 56-page report can be found at http://www.crystalra.com . Arana Therapeutics Ltd. ("Arana" or...

Bristol-Myers Squibb Issues $1.6 Billion of Senior Notes

NEW YORK, April 29 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company (NYSE: BMY ) announced today that it has agreed to sell $1.6 billion of senior unsecured notes: $600 million in aggregate principal amount of 5.450% notes due May 1, 2018 and $1 billion in aggregate principal amount of ...

SectorWatch.biz Issues MarketStats on KBLB, DGX, LH, BRLI, and ABT

IRVINE, Calif., April 23 /PRNewswire/ -- SectorWatch.biz announces the availability of MarketStats on public equities in the news and driving markets today within the biotechnology and diagnostic testing arena. MarketStats offers a perspective on the aforementioned equities and the opportunity...

VaxGen Issues Rebuttal to MedCap Letter

MedCap press releases contain false and misleading information SOUTH SAN FRANCISCO, Calif., March 25 /PRNewswire-FirstCall/-- VaxGen Inc. (OTC Bulletin Board: VXGN.OB) (Logo: http://www.newscom.com/cgi-bin/prnh/19991112/VAXGENLOGO ) Dear Stockholders, On March 19th, MedCap Manag...

FDA Issues Approvable Letter for Ceftobiprole for Treatment of Complicated Skin Infections

RARITAN, N.J., March 18 /PRNewswire/ -- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), today announced that it received an approvable letter from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ceftobiprole for the treatment o...

Medco Issues $1.5 Billion of Senior Notes

FRANKLIN LAKES, N.J., March 13 /PRNewswire-FirstCall/ -- Medco Health Solutions, Inc. (NYSE: MHS ) announced today that it has agreed to sell $300 million aggregate principal amount of 6-1/8 percent senior notes due March 15, 2013 and $1.2 billion aggregate principal amount of 7-1/8 percent s...

SectorWatch.biz Issues MarketStats on CVBT, BSX, MDT, CXM and DNA

IRVINE, Calif., Feb. 14 /PRNewswire/ -- SectorWatch.biz announces the availability of MarketStats on public equities that are in the news and driving markets today. Investors can view all of SectorWatch.biz MarketStats free of charge by visiting: http://www.SectorWatch.biz -- Click on Mark...

Solstice Neurosciences, Inc. Issues Corporate Response to FDA Early Communication

MALVERN, Pa., Feb. 8 /PRNewswire/ -- Safety of patients treated with Myobloc(R) (Botulinum Toxin Type B) Injectable Solution has always been of primary importance for Solstice Neurosciences, Inc. ("Solstice"). We support education and training of physicians in a number of ways regarding the pr...

Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics

RICHMOND, Va., Feb. 5 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM) CEO Geoffrey Allan issued the following statement today following the White House FY09 Budget and Food and Drug Administration statements on developing an approval pathway for follow-on biologics: "Insmed is very plea...

Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/mL 10 and 30mL Multi-Dose Vials

NDC NUMBERS 0641-2440-45, 0641-2440-41, 0641-2450-45 and 0641-2450-41; LOTS: 107054, 117085, 047056, 097081, 107024, 107064, 107066, 107074, 107111 DEERFIELD, Ill., Jan. 25 /PRNewswire-FirstCall/ -- Baxter Healthcare Corporation has announced the voluntary r...